These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
436 related items for PubMed ID: 8035316
1. Differential induction of 5-HT1A-mediated responses in vivo by three chemically dissimilar 5-HT1A agonists. Scott PA, Chou JM, Tang H, Frazer A. J Pharmacol Exp Ther; 1994 Jul; 270(1):198-208. PubMed ID: 8035316 [Abstract] [Full Text] [Related]
2. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: A comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635. de Boer SF, Lesourd M, Mocaer E, Koolhaas JM. J Pharmacol Exp Ther; 1999 Mar; 288(3):1125-33. PubMed ID: 10027850 [Abstract] [Full Text] [Related]
3. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity. Millan MJ, Bervoets K, Colpaert FC. J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033 [Abstract] [Full Text] [Related]
4. A drug discrimination analysis of the actions of novel serotonin1A receptor ligands in the rat using the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin. Schreiber R, Brocco M, Lefèbvre de Ladonchamps B, Monneyron S, Millan MJ. J Pharmacol Exp Ther; 1995 Nov; 275(2):822-31. PubMed ID: 7473172 [Abstract] [Full Text] [Related]
5. Analysis of the 5-HT1A receptor involvement in passive avoidance in the rat. Misane I, Johansson C, Ogren SO. Br J Pharmacol; 1998 Oct; 125(3):499-509. PubMed ID: 9806333 [Abstract] [Full Text] [Related]
7. New methoxy-chroman derivatives, 4[N-(5-methoxy-chroman-3-yl)N- propylamino]butyl-8-azaspiro-(4,5)-decane-7,9-dione [(+/-)-S 20244] and its enantiomers, (+)-S 20499 and (-)-S 20500, with potent agonist properties at central 5-hydroxytryptamine1A receptors. Kidd EJ, Haj-Dahmane S, Jolas T, Lanfumey L, Fattaccini CM, Guardiola-Lemaitre B, Gozlan H, Hamon M. J Pharmacol Exp Ther; 1993 Feb; 264(2):863-72. PubMed ID: 8094756 [Abstract] [Full Text] [Related]
8. Partial agonistic activity of R- and S-enantiomers of 8-OH-DPAT at 5-HT1A receptors. Hadrava V, Blier P, de Montigny C. J Psychiatry Neurosci; 1996 Mar; 21(2):101-8. PubMed ID: 8820175 [Abstract] [Full Text] [Related]
9. The effect of the selective 5-HT1A agonists alnespirone (S-20499) and 8-OH-DPAT on extracellular 5-hydroxytryptamine in different regions of rat brain. Casanovas JM, Lésourd M, Artigas F. Br J Pharmacol; 1997 Oct; 122(4):733-41. PubMed ID: 9375971 [Abstract] [Full Text] [Related]
17. Pharmacology of the novel 5-hydroxytryptamine1A receptor antagonist (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: inhibition of (R)-8-hydroxy-2-(dipropylamino)tetralin-induced effects. Björk L, Cornfield LJ, Nelson DL, Hillver SE, Andén NE, Lewander T, Hacksell U. J Pharmacol Exp Ther; 1991 Jul 01; 258(1):58-65. PubMed ID: 1830099 [Abstract] [Full Text] [Related]
18. [Behavioural effects of 8-OH-DPAT, a 5-HT1A agonist in rats and effects on the behaviour of antimanic drugs]. Uchitomi Y, Yamawaki S. Yakubutsu Seishin Kodo; 1987 Sep 01; 7(3):383-92. PubMed ID: 2894736 [Abstract] [Full Text] [Related]
19. Studies on the neuronal circuits involved in the discriminative stimulus effects of 5-hydroxytryptamine1A receptor agonists in the rat. Schreiber R, de Vry J. J Pharmacol Exp Ther; 1993 May 01; 265(2):572-9. PubMed ID: 8496807 [Abstract] [Full Text] [Related]